SPI1 (Transcription factor PU.1) variants and mutations

SPI1 (also known as Transcription factor PU.1) is a human protein-coding gene encoding a transcription factor PU.1 protein. It directs transcriptional programs required for myeloid and B-cell development. Altered dosage can block differentiation and cooperate in leukemia, while rare germline variants can cause immunodeficiency or predisposition to myeloid disease. This analysis covers 595 SPI1 variants and mutations. Of these, 81% have computational variant effect predictions. Disease context includes agammaglobulinemia 10, autosomal dominant, agammaglobulinemia, and neurodegenerative disease. Example SPI1 variants include L2F, L2I, and Q3*.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable SPI1 variants

Examples include L2F, L2I, Q3*, Q3E, Q3P, Q3R, A4E, A4T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.